カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

無針ドラッグデリバリーシステムの世界市場2025年：ジェット式、スプリング式、レーザー式

■ 英語タイトル：Global Needle-Free Drug Delivery Systems Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3555）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3555
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[無針ドラッグデリバリーシステムの世界市場2025年：ジェット式、スプリング式、レーザー式]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の無針ドラッグデリバリーシステム市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の無針ドラッグデリバリーシステムの市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

無針ドラッグデリバリーシステム市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・ジェット式、スプリング式、レーザー式

アプリケーション別セグメントは次のように区分されます。
・病院、診療所、その他

世界の無針ドラッグデリバリーシステム市場の主要な市場プレーヤーは以下のとおりです。
・Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、無針ドラッグデリバリーシステム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な無針ドラッグデリバリーシステムメーカーの企業概要、2022年～2024年までの無針ドラッグデリバリーシステムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な無針ドラッグデリバリーシステムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別無針ドラッグデリバリーシステムの販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までの無針ドラッグデリバリーシステムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での無針ドラッグデリバリーシステム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および無針ドラッグデリバリーシステムの産業チェーンを掲載しています。
・第13、14、15章では、無針ドラッグデリバリーシステムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 無針ドラッグデリバリーシステムの概要
– 種類別分析（2020年vs2024年vs2031年）：ジェット式、スプリング式、レーザー式
– 用途別分析（2020年vs2024年vs2031年）：病院、診療所、その他
– 世界の無針ドラッグデリバリーシステム市場規模・予測
– 世界の無針ドラッグデリバリーシステム生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：ジェット式、スプリング式、レーザー式
・用途別分析2020年-2031年：病院、診療所、その他
・無針ドラッグデリバリーシステムの北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・無針ドラッグデリバリーシステムのヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・無針ドラッグデリバリーシステムのアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・無針ドラッグデリバリーシステムの南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・無針ドラッグデリバリーシステムの中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Needle-Free Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Needle-Free Drug Delivery Systems Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 Jet-Based
1.2.3 Spring-Based
1.2.4 Laser-Based
1.3 Market Analysis by Application
1.3.1 Overview: Global Needle-Free Drug Delivery Systems Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Needle-Free Drug Delivery Systems Market Size & Forecast
1.4.1 Global Needle-Free Drug Delivery Systems Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Needle-Free Drug Delivery Systems Sales in Volume (2020-2031)
1.4.3 Global Needle-Free Drug Delivery Systems Price (2020-2031)
1.5 Global Needle-Free Drug Delivery Systems Production Capacity Analysis
1.5.1 Global Needle-Free Drug Delivery Systems Total Production Capacity (2020-2031)
1.5.2 Global Needle-Free Drug Delivery Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Needle-Free Drug Delivery Systems Market Drivers
1.6.2 Needle-Free Drug Delivery Systems Market Restraints
1.6.3 Needle-Free Drug Delivery Systems Trends Analysis
2 Manufacturers Profiles
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Needle-Free Drug Delivery Systems Product and Services
2.1.4 Antares Pharma Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Pharmajet
2.2.1 Pharmajet Details
2.2.2 Pharmajet Major Business
2.2.3 Pharmajet Needle-Free Drug Delivery Systems Product and Services
2.2.4 Pharmajet Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 Optinose
2.3.1 Optinose Details
2.3.2 Optinose Major Business
2.3.3 Optinose Needle-Free Drug Delivery Systems Product and Services
2.3.4 Optinose Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 Valeritas
2.4.1 Valeritas Details
2.4.2 Valeritas Major Business
2.4.3 Valeritas Needle-Free Drug Delivery Systems Product and Services
2.4.4 Valeritas Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.5 Crossject
2.5.1 Crossject Details
2.5.2 Crossject Major Business
2.5.3 Crossject Needle-Free Drug Delivery Systems Product and Services
2.5.4 Crossject Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.6 Injex Pharma
2.6.1 Injex Pharma Details
2.6.2 Injex Pharma Major Business
2.6.3 Injex Pharma Needle-Free Drug Delivery Systems Product and Services
2.6.4 Injex Pharma Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.7 3M Pharmaceuticals
2.7.1 3M Pharmaceuticals Details
2.7.2 3M Pharmaceuticals Major Business
2.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
2.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.8 Becton Dickinson (BD)
2.8.1 Becton Dickinson (BD) Details
2.8.2 Becton Dickinson (BD) Major Business
2.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product and Services
2.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.9 MedImmune
2.9.1 MedImmune Details
2.9.2 MedImmune Major Business
2.9.3 MedImmune Needle-Free Drug Delivery Systems Product and Services
2.9.4 MedImmune Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.10 Mystic Pharmaceuticals
2.10.1 Mystic Pharmaceuticals Details
2.10.2 Mystic Pharmaceuticals Major Business
2.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
2.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.11 Zogenix
2.11.1 Zogenix Details
2.11.2 Zogenix Major Business
2.11.3 Zogenix Needle-Free Drug Delivery Systems Product and Services
2.11.4 Zogenix Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Needle-Free Drug Delivery Systems Breakdown Data by Manufacturer
3.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Needle-Free Drug Delivery Systems Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Needle-Free Drug Delivery Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Needle-Free Drug Delivery Systems Manufacturer Market Share in 2024
3.4.2 Top 6 Needle-Free Drug Delivery Systems Manufacturer Market Share in 2024
3.5 Global Needle-Free Drug Delivery Systems Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Needle-Free Drug Delivery Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Needle-Free Drug Delivery Systems Market Size by Region
4.1.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Region (2020-2031)
4.1.2 Global Needle-Free Drug Delivery Systems Revenue by Region (2020-2031)
4.2 North America Needle-Free Drug Delivery Systems Revenue (2020-2031)
4.3 Europe Needle-Free Drug Delivery Systems Revenue (2020-2031)
4.4 Asia-Pacific Needle-Free Drug Delivery Systems Revenue (2020-2031)
4.5 South America Needle-Free Drug Delivery Systems Revenue (2020-2031)
4.6 Middle East and Africa Needle-Free Drug Delivery Systems Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Type (2020-2031)
5.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2020-2031)
5.3 Global Needle-Free Drug Delivery Systems Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Application (2020-2031)
6.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2020-2031)
6.3 Global Needle-Free Drug Delivery Systems Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
7.2 North America Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
7.3 North America Needle-Free Drug Delivery Systems Market Size by Country
7.3.1 North America Needle-Free Drug Delivery Systems Sales in Volume by Country (2020-2031)
7.3.2 North America Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
8.2 Europe Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
8.3 Europe Needle-Free Drug Delivery Systems Market Size by Country
8.3.1 Europe Needle-Free Drug Delivery Systems Sales in Volume by Country (2020-2031)
8.3.2 Europe Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
9.2 Asia-Pacific Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
9.3 Asia-Pacific Needle-Free Drug Delivery Systems Market Size by Region
9.3.1 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Needle-Free Drug Delivery Systems Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
10.2 South America Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
10.3 South America Needle-Free Drug Delivery Systems Market Size by Country
10.3.1 South America Needle-Free Drug Delivery Systems Sales in Volume by Country (2020-2031)
10.3.2 South America Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
11.2 Middle East & Africa Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
11.3 Middle East & Africa Needle-Free Drug Delivery Systems Market Size by Country
11.3.1 Middle East & Africa Needle-Free Drug Delivery Systems Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Needle-Free Drug Delivery Systems and Key Manufacturers
12.2 Manufacturing Costs Percentage of Needle-Free Drug Delivery Systems
12.3 Needle-Free Drug Delivery Systems Production Process
12.4 Needle-Free Drug Delivery Systems Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Needle-Free Drug Delivery Systems Typical Distributors
13.3 Needle-Free Drug Delivery Systems Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Needle-Free Drug Delivery Systems Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Needle-Free Drug Delivery Systems Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Antares Pharma Major Business
Table 5. Antares Pharma Needle-Free Drug Delivery Systems Product and Services
Table 6. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Pharmajet Basic Information, Manufacturing Base and Competitors
Table 8. Pharmajet Major Business
Table 9. Pharmajet Needle-Free Drug Delivery Systems Product and Services
Table 10. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. Optinose Basic Information, Manufacturing Base and Competitors
Table 12. Optinose Major Business
Table 13. Optinose Needle-Free Drug Delivery Systems Product and Services
Table 14. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. Valeritas Basic Information, Manufacturing Base and Competitors
Table 16. Valeritas Major Business
Table 17. Valeritas Needle-Free Drug Delivery Systems Product and Services
Table 18. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Crossject Basic Information, Manufacturing Base and Competitors
Table 20. Crossject Major Business
Table 21. Crossject Needle-Free Drug Delivery Systems Product and Services
Table 22. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 23. Injex Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Injex Pharma Major Business
Table 25. Injex Pharma Needle-Free Drug Delivery Systems Product and Services
Table 26. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 27. 3M Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. 3M Pharmaceuticals Major Business
Table 29. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
Table 30. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 31. Becton Dickinson (BD) Basic Information, Manufacturing Base and Competitors
Table 32. Becton Dickinson (BD) Major Business
Table 33. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product and Services
Table 34. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 35. MedImmune Basic Information, Manufacturing Base and Competitors
Table 36. MedImmune Major Business
Table 37. MedImmune Needle-Free Drug Delivery Systems Product and Services
Table 38. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 39. Mystic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Mystic Pharmaceuticals Major Business
Table 41. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
Table 42. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 43. Zogenix Basic Information, Manufacturing Base and Competitors
Table 44. Zogenix Major Business
Table 45. Zogenix Needle-Free Drug Delivery Systems Product and Services
Table 46. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 47. Global Needle-Free Drug Delivery Systems Sales by Manufacturer (2021, 2022, 2023, and 2024) & (K Units)
Table 48. Global Needle-Free Drug Delivery Systems Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 49. Market Position of Manufacturers in Needle-Free Drug Delivery Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 50. Global Needle-Free Drug Delivery Systems Production Capacity by Company, (K Units): 2023 VS 2024
Table 51. Head Office and Needle-Free Drug Delivery Systems Production Site of Key Manufacturer
Table 52. Needle-Free Drug Delivery Systems New Entrant and Capacity Expansion Plans
Table 53. Needle-Free Drug Delivery Systems Mergers & Acquisitions in the Past Five Years
Table 54. Global Needle-Free Drug Delivery Systems Sales by Region (2020-2024) & (K Units)
Table 55. Global Needle-Free Drug Delivery Systems Sales by Region (2025-2031) & (K Units)
Table 56. Global Needle-Free Drug Delivery Systems Revenue by Region (2020-2024) & (USD Million)
Table 57. Global Needle-Free Drug Delivery Systems Revenue by Region (2025-2031) & (USD Million)
Table 58. Global Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 59. Global Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 60. Global Needle-Free Drug Delivery Systems Revenue by Type (2020-2024) & (USD Million)
Table 61. Global Needle-Free Drug Delivery Systems Revenue by Type (2025-2031) & (USD Million)
Table 62. Global Needle-Free Drug Delivery Systems Price by Type (2020-2024) & (USD/Unit)
Table 63. Global Needle-Free Drug Delivery Systems Price by Type (2025-2031) & (USD/Unit)
Table 64. Global Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 65. Global Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 66. Global Needle-Free Drug Delivery Systems Revenue by Application (2020-2024) & (USD Million)
Table 67. Global Needle-Free Drug Delivery Systems Revenue by Application (2025-2031) & (USD Million)
Table 68. Global Needle-Free Drug Delivery Systems Price by Application (2020-2024) & (USD/Unit)
Table 69. Global Needle-Free Drug Delivery Systems Price by Application (2025-2031) & (USD/Unit)
Table 70. North America Needle-Free Drug Delivery Systems Sales by Country (2020-2024) & (K Units)
Table 71. North America Needle-Free Drug Delivery Systems Sales by Country (2025-2031) & (K Units)
Table 72. North America Needle-Free Drug Delivery Systems Revenue by Country (2020-2024) & (USD Million)
Table 73. North America Needle-Free Drug Delivery Systems Revenue by Country (2025-2031) & (USD Million)
Table 74. North America Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 75. North America Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 76. North America Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 77. North America Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 78. Europe Needle-Free Drug Delivery Systems Sales by Country (2020-2024) & (K Units)
Table 79. Europe Needle-Free Drug Delivery Systems Sales by Country (2025-2031) & (K Units)
Table 80. Europe Needle-Free Drug Delivery Systems Revenue by Country (2020-2024) & (USD Million)
Table 81. Europe Needle-Free Drug Delivery Systems Revenue by Country (2025-2031) & (USD Million)
Table 82. Europe Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 83. Europe Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 84. Europe Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 85. Europe Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 86. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Region (2020-2024) & (K Units)
Table 87. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Region (2025-2031) & (K Units)
Table 88. Asia-Pacific Needle-Free Drug Delivery Systems Revenue by Region (2020-2024) & (USD Million)
Table 89. Asia-Pacific Needle-Free Drug Delivery Systems Revenue by Region (2025-2031) & (USD Million)
Table 90. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 91. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 92. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 93. Asia-Pacific Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 94. South America Needle-Free Drug Delivery Systems Sales by Country (2020-2024) & (K Units)
Table 95. South America Needle-Free Drug Delivery Systems Sales by Country (2025-2031) & (K Units)
Table 96. South America Needle-Free Drug Delivery Systems Revenue by Country (2020-2024) & (USD Million)
Table 97. South America Needle-Free Drug Delivery Systems Revenue by Country (2025-2031) & (USD Million)
Table 98. South America Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 99. South America Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 100. South America Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 101. South America Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 102. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Region (2020-2024) & (K Units)
Table 103. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Region (2025-2031) & (K Units)
Table 104. Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Region (2020-2024) & (USD Million)
Table 105. Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Region (2025-2031) & (USD Million)
Table 106. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Type (2020-2024) & (K Units)
Table 107. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Type (2025-2031) & (K Units)
Table 108. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Application (2020-2024) & (K Units)
Table 109. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Application (2025-2031) & (K Units)
Table 110. Needle-Free Drug Delivery Systems Raw Material
Table 111. Key Manufacturers of Needle-Free Drug Delivery Systems Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Needle-Free Drug Delivery Systems Typical Distributors
Table 115. Needle-Free Drug Delivery Systems Typical Customers
List of Figures
Figure 1. Needle-Free Drug Delivery Systems Picture
Figure 2. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type in 2024
Figure 3. Jet-Based
Figure 4. Spring-Based
Figure 5. Laser-Based
Figure 6. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application in 2024
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Global Needle-Free Drug Delivery Systems Revenue, (USD Million) & (K Units): 2020 & 2024 & 2031
Figure 11. Global Needle-Free Drug Delivery Systems Revenue and Forecast (2020-2031) & (USD Million)
Figure 12. Global Needle-Free Drug Delivery Systems Sales (2020-2031) & (K Units)
Figure 13. Global Needle-Free Drug Delivery Systems Price (2020-2031) & (USD/Unit)
Figure 14. Global Needle-Free Drug Delivery Systems Production Capacity (2020-2031) & (K Units)
Figure 15. Global Needle-Free Drug Delivery Systems Production Capacity by Geographic Region: 2024 VS 2031
Figure 16. Needle-Free Drug Delivery Systems Market Drivers
Figure 17. Needle-Free Drug Delivery Systems Market Restraints
Figure 18. Needle-Free Drug Delivery Systems Market Trends
Figure 19. Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturer in 2024
Figure 20. Global Needle-Free Drug Delivery Systems Revenue Market Share by Manufacturer in 2024
Figure 21. Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 22. Top 3 Needle-Free Drug Delivery Systems Manufacturer (Revenue) Market Share in 2024
Figure 23. Top 6 Needle-Free Drug Delivery Systems Manufacturer (Revenue) Market Share in 2024
Figure 24. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2031)
Figure 25. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2020-2031)
Figure 26. North America Needle-Free Drug Delivery Systems Revenue (2020-2031) & (USD Million)
Figure 27. Europe Needle-Free Drug Delivery Systems Revenue (2020-2031) & (USD Million)
Figure 28. Asia-Pacific Needle-Free Drug Delivery Systems Revenue (2020-2031) & (USD Million)
Figure 29. South America Needle-Free Drug Delivery Systems Revenue (2020-2031) & (USD Million)
Figure 30. Middle East & Africa Needle-Free Drug Delivery Systems Revenue (2020-2031) & (USD Million)
Figure 31. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
Figure 32. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2020-2031)
Figure 33. Global Needle-Free Drug Delivery Systems Price by Type (2020-2031) & (USD/Unit)
Figure 34. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 35. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2020-2031)
Figure 36. Global Needle-Free Drug Delivery Systems Price by Application (2020-2031) & (USD/Unit)
Figure 37. North America Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
Figure 38. North America Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 39. North America Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
Figure 40. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
Figure 41. United States Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 42. Canada Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 43. Mexico Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 44. Europe Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
Figure 45. Europe Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 46. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
Figure 47. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
Figure 48. Germany Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 49. France Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. United Kingdom Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. Russia Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 52. Italy Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 53. Asia-Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 55. Asia-Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2031)
Figure 56. Asia-Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region (2020-2031)
Figure 57. China Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 58. Japan Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. Korea Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. India Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. Southeast Asia Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 62. Australia Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 63. South America Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
Figure 64. South America Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 65. South America Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
Figure 66. South America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
Figure 67. Brazil Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 68. Argentina Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 69. Middle East & Africa Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
Figure 70. Middle East & Africa Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
Figure 71. Middle East & Africa Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2031)
Figure 72. Middle East & Africa Needle-Free Drug Delivery Systems Revenue Market Share by Region (2020-2031)
Figure 73. Turkey Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 74. Egypt Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. Saudi Arabia Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 76. South Africa Needle-Free Drug Delivery Systems Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Needle-Free Drug Delivery Systems in 2024
Figure 78. Manufacturing Process Analysis of Needle-Free Drug Delivery Systems
Figure 79. Needle-Free Drug Delivery Systems Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

※参考情報

無針ドラッグデリバリーシステムとは、薬物を皮膚や粘膜などの生体膜を通じて注射器や針を用いずに投与するための革新的な技術であります。このシステムは、従来の注射方法に伴う痛みや不快感を軽減し、患者にとってより快適な薬物投与を実現することを目的としています。無針ドラッグデリバリーシステムは、患者のコンプライアンスの向上や医療現場での効率化に寄与すると期待されています。

無針ドラッグデリバリーシステムの主な特徴は、痛みや感染リスクを低減することです。従来の注射に比べ、針がないため、注射部位での痛みや不快感が軽減されることに加え、使い捨ての針による感染のリスクも排除されます。また、無針で薬物を投与するため、医療従事者にとっても利便性が高く、特に小児や高齢者、注射に対して恐怖心を抱く患者にとって、非常に有効な手段となり得ます。

無針ドラッグデリバリーシステムにはいくつかの種類があります。代表的なものとしては、気圧を利用したシステム、超音波を利用したシステム、ナノ粒子を用いたシステムなどがあります。気圧を利用したシステムでは、高圧ガスを用いて薬剤を皮膚に直接噴射することで、薬物を効果的に導入します。この方法は、高速で短時間で薬物を投与できる利点があります。一方で、超音波を利用したシステムでは、超音波振動を用いて皮膚のバリアを一時的に破壊し、薬物がより効果的に浸透することを助けます。このように、異なるアプローチに基づく無針ドラッグデリバリーシステムが存在し、用途に応じて選択されます。

無針ドラッグデリバリーシステムの用途は多岐にわたります。例えば、インスリン投与やワクチン接種、痛みの管理、ホルモン療法などでの活用が期待されています。特に、インスリンの無針投与は、糖尿病患者にとって大きな利点です。従来の注射に比べて、痛みが少なく、より快適な投与が可能となるため、患者の生活の質を大幅に向上させる可能性があります。また、ワクチン接種においても、無針ドラッグデリバリーシステムは新たな選択肢として注目されています。迅速かつ無痛でワクチンを接種することができ、新型コロナウイルスワクチンなどの大規模接種においても効果的に利用できるでしょう。

さらに、無針ドラッグデリバリーシステムは、最近注目されているクロニックデジタルヘルスデバイスとも相性が良いです。これにより、体に装着するデバイスから自動的に薬物を投与することができるため、より効率的な治療が実現します。例えば、慢性疾患を抱える患者に対して、必要な時に必要な量の薬物を自動で供給するシステムが構築されれば、患者の日常生活は大きく改善されることでしょう。

無針ドラッグデリバリーシステムの関連技術としては、ナノテクノロジーやバイオマテリアル、デジタルヘルス、AI（人工知能）などが挙げられます。ナノテクノロジーは、微細なスケールで薬物を設計・製造することで、体内での吸収や分布を最適化するために用いられます。これにより、薬物の効果を高めることが期待されています。バイオマテリアルは、無針ドラッグデリバリーシステムに使用される材料の選択において重要であり、生体適合性や薬物放出特性に優れた材料を用いることが求められます。また、デジタルヘルスの分野では、モバイルアプリなどの技術を用いて薬物投与の管理や患者の健康状態のモニタリングが行えるようになりつつあります。AIは、患者データを分析し、個々の患者に最適な治療法を提案するシステムの開発にも寄与しています。

無針ドラッグデリバリーシステムは、患者の負担を軽減し、効果的な治療が行える可能性を秘めた技術であり、今後の医療においてますます重要な役割を果たすことが期待されています。この分野の研究や開発が進むことで、より多くの薬剤が無針で投与可能となり、患者の生活の質を向上させる新たな治療法が提供されることを願っています。そのためには、より高性能なデバイスの開発や、規制当局との連携、臨床試験による安全性と有効性の確認が不可欠です。

総じて、無針ドラッグデリバリーシステムは、将来的な医療のあり方を変える可能性を有する、革新的なアプローチであると言えるでしょう。従来の治療法の限界を打破し、患者中心の医療を実現するための鍵となる技術として、注目され続けることでしょう。技術の進歩と医療現場との連携を通じて、無針ドラッグデリバリーシステムの普及が進むことを期待しています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 電気光学システムの世界市場2025年：赤外線式、レーザー式
  • エキゾーストリールの世界市場2025-2031：電動式、スプリング式
  • 排気ホースリールの世界市場2025-2031：電動式、スプリング式
  • 工業用コンピュータトラックボールのグローバル市場2023：機械式、レーザー式
  • 全自動型溶接ヘッドのグローバル市場2023：アーク式、トラック式、レーザー式、コンデンサ放電式
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3555 )"無針ドラッグデリバリーシステムの世界市場2025年：ジェット式、スプリング式、レーザー式" (英文：Global Needle-Free Drug Delivery Systems Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。